Sign in

CIK 0001609809

  • Non-accelerated filer
  • Smaller reporting company

Seres Therapeutics, Inc.

Sign in to watch
Ticker
MCRB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
274326290
Phone
+1 617-945-9626
Business address
200 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
Seres Therapeutics, Inc., Seres Health, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$795
in 4 filings, $795 under 10b5-1 plans

Net −$795. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 39 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-01-26 Aunins John G. Chief Technology Officer & EVP Grant or award · Stock Option (right to buy) +50,000 50,000
2017-01-26 Aunins John G. Chief Technology Officer & EVP Grant or award · Restricted Stock Units +25,000 25,000
2017-01-26 Hashad Wael EVP & Chief Commercial Officer Grant or award · Stock Option (right to buy) +75,000 75,000
2017-01-26 Hashad Wael EVP & Chief Commercial Officer Grant or award · Restricted Stock Units +25,000 25,000
2017-01-26 Shaff Eric D. CFO and EVP Grant or award · Stock Option (right to buy) +105,000 105,000
2017-01-26 Shaff Eric D. CFO and EVP Grant or award · Restricted Stock Units +40,000 40,000
2017-01-26 Trucksis Michele Chief Medical Officer and EVP Grant or award · Stock Option (right to buy) +100,000 100,000
2017-01-26 Trucksis Michele Chief Medical Officer and EVP Grant or award · Restricted Stock Units +37,500 37,500
2017-01-26 Pomerantz Roger President and CEO Grant or award · Stock Option (right to buy) +261,000 261,000
2017-01-26 COOK DAVID N Chief Scientific Officer & EVP Grant or award · Stock Option (right to buy) +75,000 75,000
2017-01-26 COOK DAVID N Chief Scientific Officer & EVP Grant or award · Restricted Stock Units +25,000 25,000
2016-09-19 Aunins John G. Chief Technology Officer & EVP Grant or award · Stock Option (right to buy) +30,000 30,000
2016-08-29 Aunins John G. Chief Technology Officer & EVP Sale −9,390 $10.87 $102K 192,125
2016-07-28 Trucksis Michele Chief Medical Officer and EVP Exercise or conversion +4,156 $15.77 $66K 4,156
2016-07-28 Trucksis Michele Chief Medical Officer and EVP Sale −4,156 $35.18 $146K 0
2016-07-28 Trucksis Michele Chief Medical Officer and EVP Exercise or conversion · Stock Option (Right to Buy) +4,156 296,904
2016-07-27 Aunins John G. Chief Technology Officer & EVP Sale −9,250 $35.00 $324K 201,515
2016-07-27 Pomerantz Roger President and CEO Exercise or conversion +20,000 $0.71 $14K 203,692
2016-07-27 Pomerantz Roger President and CEO Sale −20,000 $35.00 $700K 183,692
2016-07-27 Pomerantz Roger President and CEO Exercise or conversion · Stock Option (right to buy) −20,000 1,052,286

Page 31 of 34 · 662 trades